Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: Results from a phase 2 pilot study (VOLCANO-1). Have a read: https://www.m3india.in/contents/journal/the-neurokinin-1-receptor-antagonist-orvepitant?utm_campaign=unset&utm_medium=share&utm_source=ref_wa